Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. - Test2 - elhamkhani - TriplyDB

Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.

Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34419898

about

Nature and Treatment of Comorbid Alcohol Problems and Post Traumatic Stress Disorder Among American Military Personnel and Veterans In the Clinic. Alcohol Use Alcoholic liver disease and hepatitis C virus infection Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials Guidelines for the Reporting of Treatment Trials for Alcohol Use Disorders Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders Primary care management of alcohol use disorder and at-risk drinking: Part 2: counsel, prescribe, connect Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care Acamprosate: A Review of Its Use in Alcohol Dependence Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs.Unhealthy alcohol use in older adults: Association with readmissions and emergency department use in the 30 days after hospital discharge Patient-centered primary care for adults at high risk for AUDs: the Choosing Healthier Drinking Options In primary CarE (CHOICE) trial.Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery Prevention, early intervention, and harm reduction of substance use in adolescents.First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario.Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects.Comparison of DSM-IV and DSM-5 criteria for alcohol use disorders in VA primary care patients with frequent heavy drinking enrolled in a trial.Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.Adoption of injectable naltrexone in U.S. substance use disorder treatment programs Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate.An inpatient treatment and discharge planning protocol for alcohol dependence: efficacy in reducing 30-day readmissions and emergency department visits.The prescription of addiction medications after implementation of chronic care management for substance dependence in primary care Effects of idazoxan on alcohol pharmacokinetics and intoxication: a preliminary human laboratory study.A systemic failure to address at-risk drinking and alcohol use disorders: the Canadian story Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders PURLs: Consider these medications to help patients stay sober.Nalmefene and alcohol dependence: A new approach or the same old unacceptable marketing?Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.Alcohol-Related Diagnoses and All-Cause Hospitalization Among HIV-Infected and Uninfected Patients: A Longitudinal Analysis of United States Veterans from 1997 to 2011.Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.Brief Intervention Decreases Drinking Frequency in HIV-Infected, Heavy Drinking Women: Results of a Randomized Controlled Trial.Advances in alcoholic liver disease: An update on alcoholic hepatitis The Impact of Alcohol Use and Related Disorders on the HIV Continuum of Care: a Systematic Review : Alcohol and the HIV Continuum of Care.Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study.Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers.

P2860

Q26751076-7DF85B6E-6B63-4C02-946E-08E059B9060C Q26770054-5134EB4B-6702-40B2-BB8D-5CA5933A3463 Q26773274-EF3E9A09-61DB-4F9D-913C-64261E8253FE Q26773290-38E0BF3B-9144-42E8-8CC3-605A14E055DD Q26779440-749C17A4-0D79-43E6-802E-6ACE2977C03C Q26801196-F477A15C-5467-48A2-ABED-E0EB4AB16906 Q27013929-F4BE1424-97CB-42FD-8E52-D58624F372E6 Q27693265-049D8DF7-96E6-4B05-B057-3F27320B7141 Q28081029-A238091A-938F-4457-ACCC-8F29A83CD698 Q28263633-F7C194D7-0FFE-45AA-80B6-22378326E8D9 Q28390909-12A11333-1765-4ED7-B6AF-0F6D9590E977 Q30401713-625C8A9C-6766-4938-ABBA-0C150C2E24A5 Q30710117-E0738E2C-FC7D-4784-BEB8-8C175A85D622 Q30851487-7D7530CD-4DB3-4620-B3BA-E41995C54E96 Q31039835-16F59757-83A9-4839-AA96-9DEBE9A65CE8 Q33635582-F4E2A573-AC76-43AE-8519-C1274D6073D0 Q33641576-9F7C63D1-E2F7-4FA2-BFA9-FA60E51981EA Q33675540-B865999A-CF0E-469F-A041-E63A12742840 Q33746846-D6E573D9-4CAA-4C34-BB80-3F19A8BC0563 Q33912934-DAA514ED-1D39-446E-A89A-0DE0F2735FA1 Q34389080-EEBD3B0A-637F-4513-93A0-7BEB54561A55 Q34461886-377245F1-9947-4FCC-9B03-03829DCEBF90 Q34682257-9D47D668-AF77-47DD-89C9-06D0669EC751 Q35150158-B99298F6-8F21-468E-A34A-0627AF2C27FA Q35152511-2D9F232F-E5A6-48DF-8B38-FD6A9B918BD8 Q35243514-BDE931AA-44FE-451E-9520-92D00469F68C Q35256306-D6AAB405-AE21-4E64-8AAD-3920B1281982 Q35463080-AA2CB463-2FBB-43EB-A12F-62D48E88F1D2 Q35527075-4D06F523-C70F-4B56-BAA0-5BCA5A088E18 Q35543141-57FCF3E0-ABFC-4A36-8A51-A0400BC48794 Q35822064-D933FB2C-8027-4AB8-9B6B-3277E60D7E61 Q35892818-CF84E037-5418-4FC2-9B4F-A6F7C59FEE21 Q35998519-A0DFC959-824D-46DD-8D88-53E31648CA36 Q36043383-9BAE4CF9-B7B5-464B-880A-B2838AE92228 Q36231851-B7E05636-A4A1-4B4C-B4A5-A8C22C87DC76 Q36250974-3F315F7C-D60C-44FC-83A0-88BAA8A168F4 Q36269638-07FF65D6-906F-4ABC-B8FC-A678A6A50DA6 Q36275929-D8A4490B-CDD6-46A6-B2F1-44E1E5F6552E Q36314750-716E0F3C-30E9-4E86-9F8B-75E6581B8809 Q36363819-393E17D4-8C70-46BF-8457-88C6211649A9

P2860

Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34419898

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Pharmacotherapy for adults wit ...... atic review and meta-analysis.

@ast

Pharmacotherapy for adults wit ...... atic review and meta-analysis.

@en

Pharmacotherapy for adults wit ...... atic review and meta-analysis.

@nl

type

label

Pharmacotherapy for adults wit ...... atic review and meta-analysis.

@ast

Pharmacotherapy for adults wit ...... atic review and meta-analysis.

@en

Pharmacotherapy for adults wit ...... atic review and meta-analysis.

@nl

prefLabel

Pharmacotherapy for adults wit ...... atic review and meta-analysis.

@ast

Pharmacotherapy for adults wit ...... atic review and meta-analysis.

@en

Pharmacotherapy for adults wit ...... atic review and meta-analysis.

@nl

P1433

Q34419898-54DB9664-BC22-4218-BC80-3F83F9E3888F

P1476

Q34419898-75D1A6BE-F2BD-4DCF-B7A7-4DE3051F78B7

P2093

Q34419898-0FFFAA82-D323-46CF-9614-EF7351E8F2B2

Q34419898-489F4698-0886-49C3-95FF-E12930EF35DF

Q34419898-7A22B5E4-81F7-4A40-A8EF-225F82920648

Q34419898-81FED4D8-E8F6-4FC7-86CB-1393DF5896A7

Q34419898-877BCE00-E8A5-41D6-9708-8398DF952F25

Q34419898-9399903E-6062-46BF-9BFE-1C11E5F3EFF5

Q34419898-A5CA7D48-572A-4837-8E51-F4A5E73B651B

Q34419898-DA375C87-37B1-4A5E-8DF9-3CD6CE34645B

Q34419898-DE652FC1-B06D-45DD-8756-506535D91282

Q34419898-E725519D-2A54-471F-90BC-2DD7E24D74D3

P304

Q34419898-F669DDD2-1B19-47B4-ABD6-3047C3C845B6

P31

Q34419898-06DD0257-2B37-45D3-876A-C7309D3ADA90

Q34419898-969e9ed1-f152-4908-990b-d6cebbb70582

P356

Q34419898-A3C3F9BD-EA5E-4D53-A172-704D544057D0

P407

Q34419898-8F1A1AE1-B058-451B-8BDD-10C74D3090CE

P433

Q34419898-6F196C54-3597-4079-9808-201A38A5309B

P478

Q34419898-A11B9B94-CC2D-46B3-B9B2-C9EAD5A0062C

P577

Q34419898-8A993EF7-BA4C-4851-BE32-C58C03E519AD

P5875

Q34419898-2C36C43E-A506-41F4-9E38-2CF3AEEA247B

P698

Q34419898-60E54AA7-5179-4F96-AB29-216C48941D3D

P921

Q34419898-6191E65E-5289-443A-9D48-F0CBAD7BEC13

Q34419898-8E471EDC-F15E-4D7D-AF27-47F538BF635D

Q34419898-9BF23847-ECFC-491B-9FFE-D9605ABF6845

P356

P1433

Journal of the American Medical Association

P1476

Pharmacotherapy for adults wit ...... atic review and meta-analysis.

@en

P2093

C Elizabeth Gass

http://www.w3.org/2001/XMLSchema#string

Cassandra J Rowe

http://www.w3.org/2001/XMLSchema#string

Cynthia Feltner

http://www.w3.org/2001/XMLSchema#string

Daniel E Jonas

http://www.w3.org/2001/XMLSchema#string

Ellen Shanahan

http://www.w3.org/2001/XMLSchema#string

Georgiy Bobashev

http://www.w3.org/2001/XMLSchema#string

Halle R Amick

http://www.w3.org/2001/XMLSchema#string

James C Garbutt

http://www.w3.org/2001/XMLSchema#string

Kathleen Thomas

http://www.w3.org/2001/XMLSchema#string

Mimi M Kim

http://www.w3.org/2001/XMLSchema#string

P304

1889-1900

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2014.3628

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

311

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262306132

http://www.w3.org/2001/XMLSchema#string

P698

24825644

http://www.w3.org/2001/XMLSchema#string

P921

alcohol consumption

pharmacotherapy